TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Tolerance of bowel preparation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cocaine use reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in BX errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in AY errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C(max) geometric mean ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-720 min) geometric mean ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Activities Questionnaire total and subscale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease of at least 3 points in the WI‐NRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinically significant lesions on the left anterior descending artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: clinically significant lesions on the left circumflex artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: multivessel CAD prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recovery rates below SPIN clinical cut-off
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically controlled rate
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VAS scores during biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distinction between MG and HC based on metabolomic profiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of laser therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma C(max) of naltrexone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma AUC(0-t) of naltrexone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration of naltrexone below lower limit of quantitation
Endpoint domain: Adverse events/effects
Primary endpoint: Successful delivery of placenta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change of Insight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance for Affects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interrater and intrarater reliability scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: upper lip, nasal form, and cleft side profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of high-risk findings at the third examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sevoflurane concentration required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: catheter infection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cough efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIMI grade 3 flow of the infarct-related artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: treatment effectiveness for threshold ROP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for retreatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Elevated free cortisol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: ACTH responses in subacute and prolonged phases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Lack of palpitations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PVC burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epicardial origin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: perception of postsurgical discomfort
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: satisfaction after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: difficulty with symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objectively assessed errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Achievement of final proficiency benchmark
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Endoscopy score for oedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total survival rates (TS)
Endpoint domain: Mortality/survival
Primary endpoint: Tumor-free survival rates (TFS)
Endpoint domain: Mortality/survival
Primary endpoint: Time taken to provide an effective airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mouth trauma frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Insertion attempts required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left atrial maximal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time constant of LV relaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LA work during contraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean amounts of pethidine used after surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: frequent serious no-flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Social interactions
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Parent-child relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety risk associated with moxifloxacin injection
Endpoint domain: Adverse events/effects
Primary endpoint: mean decrease in serum cortisol concentrations AUC(0‐24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Complication rate after ileostomy formation
Endpoint domain: Adverse events/effects
Primary endpoint: Complication rate after ileostomy takedown
Endpoint domain: Adverse events/effects
Primary endpoint: Length of hospital stay for recipients with complications
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Smo₂ decline during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Heart Rate (HR) increase during BFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Perceived Exertion (RPE) increase during BFR
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: SBI (Satisfaction with Bodily Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: voice identification performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IADL disability reduction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mobility and integrated physical performance gains
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sensory threshold for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Esophageal compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reactivity of the esophagus to balloon distention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cumulative amount of delivered fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of delivered and requested PCA doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: regional health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: proportion of patients discharged from rehabilitation by the fourth post-operative day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: day of first mobilisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of osteoarthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Plasma level of endostatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: virologic suppression <200 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count of T-suppressor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Effective rate of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median absolute and percentage CD4 count increases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median p24‐antigen level decreases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median plasma viraemia level decreases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: TNF-α concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Alleviation of fasciculations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor response to electrical stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: AUC of PZQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax of PZQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Quality of care sum score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain score variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative patient‐controlled morphine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma triacylglycerol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 10-year risk of myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Intratumoral blood flow detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Resistance Index (RI) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Pulsatility Index (PI) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attainment of remission after week 42
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of acute avoidable hospital admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reduction in MMP-9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hs-CRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin dosage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma triglycerides reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Presepsin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score of haemoptysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stable sinus rhythm off antiarrhythmic medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Isometric knee extension force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: self-efficacy scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intention not to prescribe antibiotics
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: simulated behaviour
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Helpfulness rating of the CCE booklet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of remaining osteotomy size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: number of wound complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volume of seroma production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of seroma production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ankle dorsiflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in stress levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Consultation frequency
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of clinical events among non-responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of soluble P-selectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSFI overall score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-stent minimal luminal diameter (MLD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter-technique intra-class correlation coefficient (ICC) for MLA measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-arm CT imaging quality rated as good or excellent
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adherence to regimens
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvements in carrying out everyday tasks
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: maximum reduction in forearm blood flow (FBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: fewer physical complaints
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: completion rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: ease of intake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: readiness to change drinking score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent change in HDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in Apo A-I levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent change in LDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shear force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived quality of antenatal care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Waiting time for antenatal visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum alpha‐L‐fucosidase activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of serum alpha‐L‐fucosidase in diagnosing epithelial ovarian tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of serum alpha‐L‐fucosidase in diagnosing epithelial ovarian tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days gained in utero
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent remaining undelivered at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent remaining undelivered at 72 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in reported illness beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of callers who sought unadvised medical care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of callers who received unadvised significant care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of questionnaires properly completed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proliferative response rates to vaccine antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Injection site erythema (>or=5 mm)
Endpoint domain: Adverse events/effects
Primary endpoint: worse outcome at 3 months post-SAH
Endpoint domain: Mortality/survival
Primary endpoint: Long-term alanine aminotransferase (ALT) normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Duration of scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain relieving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CDAI decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: HBI decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Corticosteroid dosage decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area of hyperalgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Area of allodynia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of recurrence of anal condylomata
Endpoint domain: Mortality/survival
Primary endpoint: Functioning alarms after 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds of false alarms
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease of TC, LDL-C, TG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase of erythrocytes membrane fluidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to onset of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: magnitude of summed ST segment changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of stroke, myocardial infarction (MI) and death
Endpoint domain: Mortality/survival
Primary endpoint: Knee extensor and ankle plantar flexor three‐repetition maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak torque levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: POGO scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Needle redirection frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Short-term reproducibility (RP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term reproducibility (RP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median survival of filters
Endpoint domain: Mortality/survival
Primary endpoint: 5-, 10-, and 15-year survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Complications related to tracheostomy
Endpoint domain: Adverse events/effects
Primary endpoint: ΔMIP (change in maximal inspiratory pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (EQ5D)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adequate level of care assignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time in sedation target
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ventilator weaning process duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time efficiency of exam room teaching
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for exam room teaching
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Ventilator-Associated Pneumonia (VAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: PICU stay duration
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Mortality rate
Endpoint domain: Mortality/survival
Endpoint subdomain: null
Primary endpoint: Proportion of women undelivered at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of women undelivered at 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Amount of urine produced
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: BMI at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes